LoginGet started
Picture of Choong Ang Vaccine Laboratory logo

072020 — Choong Ang Vaccine Laboratory Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Choong Ang Vaccine Laboratory, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,8543,1647,6024,0445,998
Depreciation
Amortisation
Non-Cash Items1,5581,720-1,6981,7742,240
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital495-958616-4,787-1,045
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities8,2998,31611,5257,08612,706
Capital Expenditures-6,773-15,404-14,366-7,170-1,918
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,8042,2562,366-2,012-1,505
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-3,969-13,148-12,000-9,181-3,423
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,0113,929-877-1,600-2,813
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,412-1,116-944-3,4896,541